237 results Stibbe advises Aedifica Stibbe advises Aedifica, a Belgian listed company investing in health care real estate, on its acquisition of four senior housing sites in The Netherlands. Stibbe represents Mylan On 27 July 2015, Teva Pharmaceutical Industries announced that it has withdrawn its previously announced hostile bid to acquire Mylan N.V. Stibbe represented Mylan in this successful takeover defence and advised Mylan on both litigation and EU competition Stibbe advises a company in the chemical industry Stibbe advises a company in the chemical industry on a regulation case about safety standards. Stibbe advises a transport organisation Advising a transport organisation on the implementation of new regulation standards. Stibbe advises a financial organisation Advising a financial organisation how to avoid the publication of a sanction imposed by the regulator. Stibbe advises an international fast moving consumer goods company Advising an international fast moving consumer goods company on IT and privacy related matters, such as the use of cloud computing and the transfer of personal data outside of the European Economic Area. Stibbe advises Amsterdam RAI Advising Amsterdam RAI, the largest Dutch congress and convention center, on e-commerce and privacy related matters. Stibbe advises a large municipality Stibbe advises companies with regard to investigations of the Social Affairs and Employment (SAE) Inspectorate Providing legal assistance to several companies with regard to investigations of the Social Affairs and Employment Inspectorate (SAE, in Dutch: Inspectie Sociale Zaken en Werkgelegenheid) and imposed fines under the Foreign Nationals (Employment) Act. Stibbe advises Akzo Nobel Stibbe advised Akzo Nobel in an action before the General Court to prevent the European Commission from publishing information originating from leniency documents. Stibbe advises Credit Suisse Stibbe advised Credit Suisse on the imposement of a fine by the European Commission for participating in a cartel involving interest rate products denominated in Swiss francs. Stibbe advises Tornier Stibbe advises Tornier N.V. on its merger with Wright Medical Group, Inc. in an all stock transaction with a combined equity value of approximately $3.3 billion. Stibbe advises Mylan Stibbe advises Mylan Inc., the pharmaceuticals company listed on the NASDAQ with a market cap of approximately $19 billion, on the inversion acquisition of Abbott’s non-U.S. developed markets specialty and branded generics business. Stibbe advises Pilkington Successfully defended Pilkington in proceedings against an ACM decision to impose a fine for alleged participation in a cartel in the double-glass sector. Stibbe advises Aalberts Industries Successfully defended Aalberts Industries in a Commission appeal against a General Court judgment that had struck down a EUR 100+ million fine imposed on Aalberts. Stibbe advises Mars Representing Mars in legal proceedings before the District Court against Nestlé on allegations of abuse of dominance in the chocolate market. Stibbe advises AkzoNobel Assisting AkzoNobel in proceedings before the EU General Court concerning the European Commission's attempt to re-publish an extended non-confidential version of the hydrogen peroxide cartel decision (that includes leniency information). Stibbe advises Aedifica Stibbe advised Aedifica recently on two transactions in order to further expand her Dutch portfolio of care assets. Pagination Previous page Page 10 Current page 11 Page 12 Page 13 Next page
Stibbe advises Aedifica Stibbe advises Aedifica, a Belgian listed company investing in health care real estate, on its acquisition of four senior housing sites in The Netherlands.
Stibbe represents Mylan On 27 July 2015, Teva Pharmaceutical Industries announced that it has withdrawn its previously announced hostile bid to acquire Mylan N.V. Stibbe represented Mylan in this successful takeover defence and advised Mylan on both litigation and EU competition
Stibbe advises a company in the chemical industry Stibbe advises a company in the chemical industry on a regulation case about safety standards.
Stibbe advises a transport organisation Advising a transport organisation on the implementation of new regulation standards.
Stibbe advises a financial organisation Advising a financial organisation how to avoid the publication of a sanction imposed by the regulator.
Stibbe advises an international fast moving consumer goods company Advising an international fast moving consumer goods company on IT and privacy related matters, such as the use of cloud computing and the transfer of personal data outside of the European Economic Area.
Stibbe advises Amsterdam RAI Advising Amsterdam RAI, the largest Dutch congress and convention center, on e-commerce and privacy related matters.
Stibbe advises companies with regard to investigations of the Social Affairs and Employment (SAE) Inspectorate Providing legal assistance to several companies with regard to investigations of the Social Affairs and Employment Inspectorate (SAE, in Dutch: Inspectie Sociale Zaken en Werkgelegenheid) and imposed fines under the Foreign Nationals (Employment) Act.
Stibbe advises Akzo Nobel Stibbe advised Akzo Nobel in an action before the General Court to prevent the European Commission from publishing information originating from leniency documents.
Stibbe advises Credit Suisse Stibbe advised Credit Suisse on the imposement of a fine by the European Commission for participating in a cartel involving interest rate products denominated in Swiss francs.
Stibbe advises Tornier Stibbe advises Tornier N.V. on its merger with Wright Medical Group, Inc. in an all stock transaction with a combined equity value of approximately $3.3 billion.
Stibbe advises Mylan Stibbe advises Mylan Inc., the pharmaceuticals company listed on the NASDAQ with a market cap of approximately $19 billion, on the inversion acquisition of Abbott’s non-U.S. developed markets specialty and branded generics business.
Stibbe advises Pilkington Successfully defended Pilkington in proceedings against an ACM decision to impose a fine for alleged participation in a cartel in the double-glass sector.
Stibbe advises Aalberts Industries Successfully defended Aalberts Industries in a Commission appeal against a General Court judgment that had struck down a EUR 100+ million fine imposed on Aalberts.
Stibbe advises Mars Representing Mars in legal proceedings before the District Court against Nestlé on allegations of abuse of dominance in the chocolate market.
Stibbe advises AkzoNobel Assisting AkzoNobel in proceedings before the EU General Court concerning the European Commission's attempt to re-publish an extended non-confidential version of the hydrogen peroxide cartel decision (that includes leniency information).
Stibbe advises Aedifica Stibbe advised Aedifica recently on two transactions in order to further expand her Dutch portfolio of care assets.